An Imaging Study to Determine Changes in Brain Glucose Metabolism and Cerebral Blood Flow after Single-Dose of CST-101 in Healthy Subjects and Patients with Mild Cognitive Impairment

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2019
This article has no abstract
Epistemonikos ID: 76850b50eafd209849d9ba02e7a69531e57c7f1d
First added on: Feb 23, 2025